Monoclonal antibodies against ROR1 induce apoptosis of chronic lymphocytic leukemia (CLL) cells. (Q45876740)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22289919%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

title

Monoclonal antibodies against ROR1 induce apoptosis of chronic lymphocytic leukemia (CLL) cells (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22289919%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

1 reference

1 reference

chronic lymphocytic leukemia

1 reference

inferred from title

author

Mohammad Hojjat-Farsangi

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22289919%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

Salam Khan

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22289919%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

Mahmood Jeddi-Tehrani

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22289919%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

Mohammad Mehdi Akhondi

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22289919%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

author name string

A H Daneshmanesh

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22289919%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

A A Bayat

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22289919%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

R Ghods

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22289919%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

A-R Mahmoudi

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22289919%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

R Hadavi

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22289919%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

A Österborg

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22289919%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

F Shokri

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22289919%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

H Rabbani

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22289919%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

H Mellstedt

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22289919%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

publication date

6 January 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22289919%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22289919%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

volume

26

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22289919%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22289919%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

page(s)

1348-1355

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22289919%20AND%20SRC:MED&resulttype=core&format=json

Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines

21 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.362

From pathogenesis to treatment of chronic lymphocytic leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.362

Ofatumumab, a novel anti-CD20 monoclonal antibody for the treatment of B-cell malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.362

Management guidelines for the use of alemtuzumab in chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.362

Ofatumumab as single-agent CD20 immunotherapy in fludarabine-refractory chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.362

Addition of rituximab to fludarabine and cyclophosphamide in patients with chronic lymphocytic leukaemia: a randomised, open-label, phase 3 trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.362

Rituximab plus fludarabine and cyclophosphamide prolongs progression-free survival compared with fludarabine and cyclophosphamide alone in previously treated chronic lymphocytic leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.362

Novel anticancer targets: revisiting ERBB2 and discovering ERBB3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.362

Targeting the epidermal growth factor receptor in epithelial ovarian cancer: current knowledge and future challenges.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.362

Trastuzumab--mechanism of action and use in clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.362

Ror receptor tyrosine kinases: orphans no more

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.362

The protein tyrosine kinase family of the human genome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.362

Expression and function of the Ror-family receptor tyrosine kinases during development: lessons from genetic analyses of nematodes, mice, and humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.362

Post-translational modifications regulate signalling by Ror1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.362

Epigenetic regulation of WNT signaling in chronic lymphocytic leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.362

Wnt5a induces homodimerization and activation of Ror2 receptor tyrosine kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.362

Neurite extension in central neurons: a novel role for the receptor tyrosine kinases Ror1 and Ror2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.362

Wnt5a regulates distinct signalling pathways by binding to Frizzled2

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.362

Unique cell surface expression of receptor tyrosine kinase ROR1 in human B-cell chronic lymphocytic leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.362

Ror1, a cell surface receptor tyrosine kinase is expressed in chronic lymphocytic leukemia and may serve as a putative target for therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.362

Antisera induced by infusions of autologous Ad-CD154-leukemia B cells identify ROR1 as an oncofetal antigen and receptor for Wnt5a

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.362

Dendritic cells in patients with non-progressive B-chronic lymphocytic leukaemia have a normal functional capability but abnormal cytokine pattern

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.362

The effect of 17 sesquiterpenes on cell viability and telomerase activity in the human ovarian cancer cell line HO-8910.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.362

Characterization of new human CD20 monoclonal antibodies with potent cytolytic activity against non-Hodgkin lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.362

Nutlin-3 downregulates the expression of the oncogene TCL1 in primary B chronic lymphocytic leukemic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.362

The B-cell tumor-associated antigen ROR1 can be targeted with T cells modified to express a ROR1-specific chimeric antigen receptor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.362

Silencing of ROR1 and FMOD with siRNA results in apoptosis of CLL cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.362

Carboxypeptidase Z (CPZ) links thyroid hormone and Wnt signaling pathways in growth plate chondrocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.362

Extrinsic versus intrinsic apoptosis pathways in anticancer chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.362

VEGF receptor phosphorylation status and apoptosis is modulated by a green tea component, epigallocatechin-3-gallate (EGCG), in B-cell chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.362

Effect of human blood mononuclear cell populations in antibody dependent cellular cytotoxicity (ADCC) using two murine (CO17-1A and Br55-2) and one chimeric (17-1A) monoclonal antibodies against a human colorectal carcinoma cell line (SW948).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.362

Levels of expression of CD19 and CD20 in chronic B cell leukaemias

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.362

Performance of calibration standards for antigen quantitation with flow cytometry in chronic lymphocytic leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.362

Use of the receptor tyrosine kinase-like orphan receptor 1 (ROR1) as a diagnostic tool in chronic lymphocytic leukemia (CLL).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.362

Homodimers but not monomers of Rituxan (chimeric anti-CD20) induce apoptosis in human B-lymphoma cells and synergize with a chemotherapeutic agent and an immunotoxin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.362

Characterization of a new humanized anti-CD20 monoclonal antibody, IMMU-106, and Its use in combination with the humanized anti-CD22 antibody, epratuzumab, for the therapy of non-Hodgkin's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.362

The biological activity of human CD20 monoclonal antibodies is linked to unique epitopes on CD20.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.362

Monoclonal antibodies: versatile platforms for cancer immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.362

Therapeutic potential and challenges of targeting receptor tyrosine kinase ROR1 with monoclonal antibodies in B-cell malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.362

The binding site for C1q on IgG

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.362

Cetuximab and panitumumab: are they interchangeable?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.362

7 January 2021

Spontaneous programmed death (apoptosis) of B-chronic lymphocytic leukaemia cells following their culture in vitro

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.362

7 January 2021

ROR1 expression is not a unique marker of CLL

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.362

7 January 2021

Growth factor receptor tyrosine kinases

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.362

7 January 2021

The chimeric anti-CD20 antibody rituximab induces apoptosis in B-cell chronic lymphocytic leukemia cells through a p38 mitogen activated protein-kinase-dependent mechanism

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.362

7 January 2021

Identifiers

DOI

10.1038/LEU.2011.362

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22289919%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

21 January 2020

1032874765

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22289919%20AND%20SRC:MED&resulttype=core&format=json